10-K Filing

Processa Pharmaceuticals, Inc. CIK: 1533743 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001493152-22-008156`
Period End Date	20211231
Filing Date	20220330
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 24 Cash Flow Statement 72 Stockholders Equity 25

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	15.71M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.18M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.42M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.18M	shares	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	-	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$154.73K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	15.71M	shares	Point-in-time
Due from tax agencies	`DueFromTaxAgencies`	$70.27K	USD	Point-in-time
Due from tax agencies	`DueFromTaxAgencies`	$77.02K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.76M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$554.71K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$16.20M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$18.33M	USD	Point-in-time
Software	`CapitalizedComputerSoftware`	$19.74K	USD	Point-in-time
Software	`CapitalizedComputerSoftware`	$19.74K	USD	Point-in-time
Office equipment	`MachineryAndEquipment`	$9.33K	USD	Point-in-time
Office equipment	`MachineryAndEquipment`	$9.33K	USD	Point-in-time
Total Cost	`PropertyPlantAndEquipmentGross`	$29.07K	USD	Point-in-time
Total Cost	`PropertyPlantAndEquipmentGross`	$29.07K	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$29.07K	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$28.58K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$484.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$74.18K	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$158.56K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.85M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.06M	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Security deposit	`SecurityDeposit`	$5.54K	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$8.14M	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$9.01M	USD	Point-in-time
Total Assets	`Assets`	$26.46M	USD	Point-in-time
Total Assets	`Assets`	$25.21M	USD	Point-in-time
Note payable Paycheck Protection Program, current portion	`NotesPayableCurrent`	-	USD	Point-in-time
Note payable Paycheck Protection Program, current portion	`NotesPayableCurrent`	$117.57K	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$87.20K	USD	Point-in-time
Current maturities of operating lease liability	`OperatingLeaseLiabilityCurrent`	$71.08K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$950.00	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$218.91K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$320.69K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$400.00K	USD	Point-in-time
Due to licensor	`DueToLicensor`	$400.00K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.77K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$69.86K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$279.26K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$224.68K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.22M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$971.02K	USD	Point-in-time
Note payable Paycheck Protection Program	`NotesPayable`	-	USD	Point-in-time
Note payable Paycheck Protection Program	`NotesPayable`	$44.88K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$78.46K	USD	Point-in-time
Non-current operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$7.38K	USD	Point-in-time
Non-current due to licensor	`NoncurrentDueToLicensor`	-	USD	Point-in-time
Non-current due to licensor	`NoncurrentDueToLicensor`	$400.00K	USD	Point-in-time
Net deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$530.61K	USD	Point-in-time
Net deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.27M	USD	Point-in-time
Total Liabilities	`Liabilities`	$978.40K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.0001, 30,000,000 shares authorized; 15,710,246 and 14,181,734 issued and outstanding at December 31, 2021 and 2020, respectively	`CommonStockValue`	$1.42K	USD	Point-in-time
Common stock, par value $0.0001, 30,000,000 shares authorized; 15,710,246 and 14,181,734 issued and outstanding at December 31, 2021 and 2020, respectively	`CommonStockValue`	$1.57K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$48.33M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$62.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-36.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-25.40M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$8.01M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$22.94M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$25.49M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$25.21M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$26.46M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$3.17M	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$6.88M	USD	Annual
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	$566.58K	USD	Annual
Acquisition of in-process research and development	`ResearchAndDevelopmentInProcess`	$8.70M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.69M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.26M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-12.13M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-15.14M	USD	Annual
Forgiveness of Payroll Protection Program loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	Annual
Forgiveness of Payroll Protection Program loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	Annual
Interest expense	`InterestExpense`	$281.12K	USD	Annual
Interest expense	`InterestExpense`	$362.00	USD	Annual
Interest income	`InvestmentIncomeInterest`	$3.17K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$11.99K	USD	Annual
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.96M	USD	Annual
Net Operating Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-15.41M	USD	Annual
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-1.00M	USD	Annual
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-530.61K	USD	Annual
Net Loss	`NetIncomeLoss`	$-11.43M	USD	Annual
Net Loss	`NetIncomeLoss`	$-14.41M	USD	Annual
Net Loss Per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.75	USD	Annual
Net Loss Per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-2.54	USD	Annual
Net Loss Per Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.50M	shares	Annual
Net Loss Per Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.32M	shares	Annual

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-11.43M	USD	Annual
Net Loss	`NetIncomeLoss`	$-14.41M	USD	Annual
Depreciation	`Depreciation`	$8.45K	USD	Annual
Depreciation	`Depreciation`	$484.00	USD	Annual
Non-cash lease expense for right-of-use assets	`OperatingLeaseExpense`	$78.29K	USD	Annual
Non-cash lease expense for right-of-use assets	`OperatingLeaseExpense`	$84.38K	USD	Annual
Non-cash acquisition of in-process research and development	`NonCashAcquisitionOfInprocessResearchAndDevelopment`	$300.00K	USD	Annual
Non-cash acquisition of in-process research and development	`NonCashAcquisitionOfInprocessResearchAndDevelopment`	$8.60M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$199.90K	USD	Annual
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$795.33K	USD	Annual
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$790.49K	USD	Annual
Deferred income tax (benefit) expense	`DeferredIncomeTaxExpenseBenefit`	$-1.00M	USD	Annual
Deferred income tax (benefit) expense	`DeferredIncomeTaxExpenseBenefit`	$-530.61K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$3.41M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.73M	USD	Annual
Forgiveness of Payroll Protection Program loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	-	USD	Annual
Forgiveness of Payroll Protection Program loan and related accrued interest	`ForgivenessOfPayrollProtectionProgramLoanAndRelatedAccruedInterest`	$163.77K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.02M	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$239.10K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-77.49K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-87.20K	USD	Annual
Accrued interest, including amounts converted into common stock	`IncreaseDecreaseInInterestPayableNet`	$81.89K	USD	Annual
Accrued interest, including amounts converted into common stock	`IncreaseDecreaseInInterestPayableNet`	$362.00	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-101.79K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$245.08K	USD	Annual
Due (from) to related parties	`IncreaseDecreaseInDueToRelatedParties`	$86.64K	USD	Annual
Due (from) to related parties	`IncreaseDecreaseInDueToRelatedParties`	$-85.19K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$77.02K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-6.75K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$11.44K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-65.41K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.72M	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.14M	USD	Annual
Net proceeds from common stock sold	`ProceedsFromIssuanceOfCommonStock`	$17.10M	USD	Annual
Net proceeds from common stock sold	`ProceedsFromIssuanceOfCommonStock`	$10.05M	USD	Annual
Line of credit payable from related party	`LineOfCreditPayableFromRelatedParty`	-	USD	Annual
Line of credit payable from related party	`LineOfCreditPayableFromRelatedParty`	$700.00K	USD	Annual
Proceeds from our Paycheck Protection Program note payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from our Paycheck Protection Program note payable	`ProceedsFromNotesPayable`	$162.46K	USD	Annual
Shares withheld to pay taxes on stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$64.40K	USD	Annual
Shares withheld to pay taxes on stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$95.21K	USD	Annual
Other	`PaymentsForOtherFinancingActivities`	-	USD	Annual
Other	`PaymentsForOtherFinancingActivities`	$186.49K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.87M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.80M	USD	Annual
Net Increase in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.72M	USD	Annual
Net Increase in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.08M	USD	Annual
Cash and Cash Equivalents - Beginning of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.42M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$691.54K	USD	Point-in-time
Cash and Cash Equivalents - Beginning of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.50M	USD	Point-in-time
Cash and Cash Equivalents - End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$15.42M	USD	Point-in-time
Cash and Cash Equivalents - End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$691.54K	USD	Point-in-time
Cash and Cash Equivalents - End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.50M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	Annual
Right-of-use asset obtained in exchange for operating lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$17.77K	USD	Annual
Right-of-use asset obtained in exchange for operating lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual
Operating lease liability	`OperatingLeaseLiabilities`	$17.77K	USD	Annual
Operating lease liability	`OperatingLeaseLiabilities`	-	USD	Annual
Net	`NonCashleaseLiabilityNet`	-	USD	Annual
Net	`NonCashleaseLiabilityNet`	-	USD	Annual
Issuance of 100,000 shares of common stock in connection with a licensing agreement which had previously been recorded as a due to licensor	`IssuanceOfSharesOfCommonStockInConnectionWithLicensingAgreementWhichHadPreviouslyBeenRecordedAsDueToLicensor`	-	USD	Annual
Issuance of 100,000 shares of common stock in connection with a licensing agreement which had previously been recorded as a due to licensor	`IssuanceOfSharesOfCommonStockInConnectionWithLicensingAgreementWhichHadPreviouslyBeenRecordedAsDueToLicensor`	$400.00K	USD	Annual
Conversion of $805,000 of Senior Convertible Debt and related accrued interest of $84,513 into 247,088 shares of common stock	`ConversionOfSeniorConvertibleDebtAndRelatedAccruedInterestIntoSharesOfCommonStock`	$-805.00K	USD	Annual
Conversion of $805,000 of Senior Convertible Debt and related accrued interest of $84,513 into 247,088 shares of common stock	`ConversionOfSeniorConvertibleDebtAndRelatedAccruedInterestIntoSharesOfCommonStock`	-	USD	Annual
Conversion of $700,000 of Line of Credit Payable with related party and related accrued interest of $18,333 into 199,537 shares of common stock	`ConversionOfLineOfCreditPayableWithRelatedPartyAndRelatedAccruedInterestOfIntoSharesOfCommonStock`	$-700.00K	USD	Annual
Conversion of $700,000 of Line of Credit Payable with related party and related accrued interest of $18,333 into 199,537 shares of common stock	`ConversionOfLineOfCreditPayableWithRelatedPartyAndRelatedAccruedInterestOfIntoSharesOfCommonStock`	-	USD	Annual
Issuance of 1,185,458 shares of common stock due to triggering the full-ratchet anti-dilution provision of common stock sold in our 2018 Private Placement Transactions	`IssuanceOfSharesOfCommonStockDueToTriggeringFullratchetAntidilution`	$119.00	USD	Annual
Issuance of 1,185,458 shares of common stock due to triggering the full-ratchet anti-dilution provision of common stock sold in our 2018 Private Placement Transactions	`IssuanceOfSharesOfCommonStockDueToTriggeringFullratchetAntidilution`	-	USD	Annual

Stockholders Equity 25 line items

Line Item	Tag	Value	Unit	Period
Payments of Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$2.10M	USD	Annual
Debt Instrument, Interest Rate, Stated Percentage	`DebtInstrumentInterestRateStatedPercentage`	0.08	pure	Point-in-time
Beginning balance, value	`StockholdersEquity`	$8.01M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$22.94M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$25.49M	USD	Point-in-time
Shares issued in connection with our 2020 offering, net of transaction costs of $2,099,363	`StockIssuedDuringPeriodinConnectionwithOfferingnetTransactionCosts`	$17.10M	USD	Annual
Shares issued in connection with license agreements	`StockIssuedDuringPeriodValueAcquisitions`	$700.00K	USD	Annual
Shares issued in connection with license agreements	`StockIssuedDuringPeriodValueAcquisitions`	$7.80M	USD	Annual
Shares issued due to full-ratchet anti-dilution adjustment	`StockIssuedvalueDueToFullratchetAntidilutionAdjustment`	-	USD	Annual
Shares issued due to full-ratchet anti-dilution adjustment, shares	`StockIssuedDueToFullratchetAntidilutionAdjustmentShares`	1.16M	shares	Annual
Conversion of LOC Agreement into shares of common stock	`ConversionOfLineOfCreditAgreementIntoCommonStock`	$718.33K	USD	Annual
Conversion of 8% Senior Convertible Notes into shares of common stock	`ConversionOfSeniorConvertibleNotesOfCommonStock`	$889.51K	USD	Annual
Stock dividend distributed due to full-ratchet anti-dilution adjustment	`StockDividendDistributedDueToFullratchetAntidilutionAdjustment`	-	USD	Annual
Fair value of warrants issued in the sale of our 2019 Senior Notes	`DebtIssuanceCostsAttributedToWarrantsIssuedInSaleOfSeniorNotes`	$197.40K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.29M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.73M	USD	Annual
Shares issued in private placement, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$9.88M	USD	Annual
Shares withheld to pay income taxes on stock-based compensation	`SharesWithheldToPayIncomeTaxOnStockbasedCompensation`	$-95.21K	USD	Annual
Shares withheld to pay income taxes on stock-based compensation	`SharesWithheldToPayIncomeTaxOnStockbasedCompensation`	$-64.40K	USD	Annual
Shares issued in ATM purchases, net of transaction costs	`StockIssuedDuringPeriodValueOther`	$173.99K	USD	Annual
Net loss	`NetIncomeLoss`	$-11.43M	USD	Annual
Net loss	`NetIncomeLoss`	$-14.41M	USD	Annual
Ending balance, value	`StockholdersEquity`	$8.01M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$22.94M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$25.49M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.